Last edition
News about "Kiora Pharmaceuticals "
Kiora Secures New Patent for Novel KIO-104 Formulation
Kiora Pharmaceuticals, Inc., a clinical-stage biotechnology company, announced that the US Patent and Trademark Office has issued a new patent (US-12,472,263) covering additional novel formulations within the KIO-100 family of compounds.
Kiora Pharmaceuticals | 03/12/2025 | By Darshana
Kiora Receives Grant from CRF for Clinical Trial Endpoints for Inherited Retinal Diseases
Kiora Pharmaceuticals has secured grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments for patients with profound blindness.
Kiora Pharmaceuticals | 15/04/2024 | By Aishwarya | 279
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy